Search
GH Research PLC
GHRSAdd to Watchlist
22.240USD
+0.540+2.49%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.38BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Thu, Feb 19
Updated: Thu, Feb 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Schonharting (Florian)
21.62%
Lynx1 Capital Advisors LLC
15.70%
BVF Partners L.P.
12.88%
RA Capital Management, LP
11.20%
RTW Investments L.P.
8.66%
Other
29.95%
Shareholders
Shareholders
Proportion
Schonharting (Florian)
21.62%
Lynx1 Capital Advisors LLC
15.70%
BVF Partners L.P.
12.88%
RA Capital Management, LP
11.20%
RTW Investments L.P.
8.66%
Other
29.95%
Shareholder Types
Shareholders
Proportion
Investment Advisor
25.77%
Individual Investor
24.23%
Hedge Fund
16.65%
Investment Advisor/Hedge Fund
12.47%
Venture Capital
12.11%
Research Firm
1.32%
Bank and Trust
0.03%
Other
7.43%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
109
46.87M
68.37%
-3.24M
2025Q4
99
44.62M
71.93%
-2.15M
2025Q3
79
43.69M
70.44%
-1.29M
2025Q2
81
63.73M
102.74%
+7.16M
2025Q1
80
63.74M
102.77%
+7.17M
2024Q4
74
51.85M
85.10%
-3.62M
2024Q3
76
51.78M
99.44%
-4.46M
2024Q2
78
51.68M
99.26%
-4.52M
2024Q1
77
50.90M
97.75%
-4.57M
2023Q4
73
50.91M
97.80%
-2.89M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Schonharting (Florian)
14.82M
23.9%
--
--
Dec 31, 2025
Lynx1 Capital Advisors LLC
10.41M
16.78%
+1.81M
+20.99%
Dec 31, 2025
BVF Partners L.P.
8.83M
14.23%
--
--
Dec 31, 2025
RA Capital Management, LP
7.68M
12.38%
--
--
Dec 31, 2025
RTW Investments L.P.
5.93M
9.57%
+364.25K
+6.54%
Dec 31, 2025
Fidelity Management & Research Company LLC
5.14M
8.28%
-191.00K
-3.59%
Dec 31, 2025
Avoro Capital Advisors LLC
1.80M
2.9%
+1.80M
--
Dec 31, 2025
Terwey (Theis)
1.78M
2.88%
-2.91M
-61.98%
Sep 30, 2025
Cormorant Asset Management, LP
1.30M
2.1%
-616.44K
-32.17%
Dec 31, 2025
Jefferies LLC
712.30K
1.15%
+2.99K
+0.42%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AdvisorShares Psychedelics ETF
5.66%
iShares MSCI Ireland ETF
0.87%
Virtus LifeSci Biotech Clinical Trials ETF
0.76%
SPDR S&P International Small Cap ETF
0.02%
ALPS Medical Breakthroughs ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
AdvisorShares Psychedelics ETF
Proportion5.66%
iShares MSCI Ireland ETF
Proportion0.87%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.76%
SPDR S&P International Small Cap ETF
Proportion0.02%
ALPS Medical Breakthroughs ETF
Proportion0%
Fidelity Nasdaq Composite Index ETF
Proportion0%
